Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, Euro 0.12 par value per share
-
Shares outstanding
-
62,254,300
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
21,301,855
-
Shares change
-
-1,013,099
-
Total reported value, excl. options
-
$239,644,411
-
Value change
-
-$1,830,525
-
Number of buys
-
14
-
Number of sells
-
8
-
Price
-
$11.25
Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) as of Q4 2022
As of 31 Dec 2022 Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) had 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,301,855 shares of stock of the company.
Largest 10 holders included FMR LLC, Foresite Capital Management IV, LLC, VIKING GLOBAL INVESTORS LP, Bain Capital Life Sciences Investors, LLC, GENERAL ATLANTIC, L.P., venBio Partners LLC, Novo Holdings A/S, Cormorant Asset Management, LP, 5AM Venture Management, LLC, and Soleus Capital Management, L.P..
This table shows 25 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.